Skip to main content


Fig. 1 | Journal of Medical Case Reports

Fig. 1

From: Evaluation of ColdZyme® Mouth Spray on prevention of upper respiratory tract infections in a boy with primary immunodeficiency: a case report

Fig. 1

Infection symptoms per week. The average percentage of various infection symptoms per week for a 12-year-old boy diagnosed as having common variable immunodeficiency and treated weekly with subcutaneous immunoglobulin G (100 to 150 mg/kg/week). ColdZyme was used twice daily during a period of 15 months and the results are compared to historically collected data for a 21-month period prior to the ColdZyme treatment

Back to article page